Becton, Dickinson and Company (BDX)
BDX Price and Sentiment
BDX Latest news
BD Launches New 'Together We Advance' Environmental, Social, Governance Strategy; Announces 2030+ Goals to Enhance Stewardship of Human Health, Communities and the Planet
2021-10-18 06:50FRANKLIN LAKES, N.J., Oct. 18, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as well as a suite of goals for 2030 and beyond that focus on enhancing stewardship of the company, the planet, community and human health.
BD's (BDX) New Manufacturing Facility to Boost Supply Readiness
2021-10-15 12:39BD's (BDX) latest manufacturing line is expected to not only boost supply capacity but also provide priority access to needles and syringes to the U.S. government.
BD's (BDX) Rotarex Atherectomy System Gets FDA 510 (k) Clearance
2021-10-14 12:38BD's (BDX) Rotarex Atherectomy System receives expanded 510 (k) clearance from the FDA that can help in the treatment of in-stent restenosis in the United States.
Becton, Dickinson And Company: R&D And M&A Could Make The Price Spike By 47%
2021-10-13 16:02BD develops, manufactures, and sells medical supplies, laboratory equipment, and diagnostic products among other products.
BD Unveils Nebraska-Based Manufacturing Capacity to Support U.S. Vaccination Agility and Preparedness
2021-10-07 06:45FRANKLIN LAKES, N.J., Oct. 7, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government's access to safety injection devices through increased manufacturing capacity and domestic supply.
BDX's Rotarex Atherectomy System Wins FDA Indication Expansion Approval
2021-10-06 08:22Becton, Dickinson And Co (NYSE: BDX) has received FDA 510(k) clearance for expanded indications for the Rotarex Atherectomy System. Related: BDX Stock Plunges Despite Q3 Earnings Topping Estimates On Recovery In Elective Volumes; Raised FY21 Guidance.
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex™ Atherectomy System
2021-10-06 06:50FRANKLIN LAKES, N.J., Oct. 6, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance for expanded indications from the U.S. Food and Drug Administration (FDA) for the Rotarex™ Atherectomy System.
Bear Of The Day: Becton, Dickinson and Co (BDX)
2021-10-05 20:50Despite a beating the number in the most recent report, this stock has fallen to the lowest Zacks Rank
BD To Announce Fiscal 2021 Fourth Quarter And Full Year Financial Results
2021-10-04 16:15FRANKLIN LAKES, N.J., Oct. 4, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its fiscal 2021 fourth quarter and full year financial results on Thursday, Nov. 4, 2021.
Here's Why You Should Retain BD (BDX) Stock in Your Portfolio
2021-09-28 13:08Investors continue to be optimistic about BD (BDX) owing to its slew of product launches and regulatory approvals.